

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 8.41989772 |
| 2 | establishment of skin barrier (GO:0061436) | 7.79375191 |
| 3 | regulation of water loss via skin (GO:0033561) | 7.42984455 |
| 4 | keratinization (GO:0031424) | 6.31180435 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.18762606 |
| 6 | negative regulation of cell killing (GO:0031342) | 6.18762606 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.68035643 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 5.44279887 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.35708132 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.25247893 |
| 11 | hemidesmosome assembly (GO:0031581) | 5.20724022 |
| 12 | detection of bacterium (GO:0016045) | 5.10602598 |
| 13 | response to interleukin-15 (GO:0070672) | 5.00236243 |
| 14 | multicellular organismal water homeostasis (GO:0050891) | 4.96145477 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.78571318 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.73298241 |
| 17 | keratinocyte differentiation (GO:0030216) | 4.70006781 |
| 18 | interferon-gamma secretion (GO:0072643) | 4.60383421 |
| 19 | tolerance induction (GO:0002507) | 4.55312818 |
| 20 | detection of other organism (GO:0098543) | 4.42748422 |
| 21 | negative T cell selection (GO:0043383) | 4.42627074 |
| 22 | water homeostasis (GO:0030104) | 4.42622898 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 4.40040154 |
| 24 | skin morphogenesis (GO:0043589) | 4.32814470 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.22433479 |
| 26 | keratinocyte proliferation (GO:0043616) | 4.10146835 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.05526575 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 4.05322954 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05026551 |
| 30 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.01917831 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.99204973 |
| 32 | regulation of natural killer cell differentiation (GO:0032823) | 3.95066343 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.93522009 |
| 34 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.93522009 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.90923892 |
| 36 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.89676324 |
| 37 | dendritic cell migration (GO:0036336) | 3.85894249 |
| 38 | phospholipid efflux (GO:0033700) | 3.85410822 |
| 39 | sphingoid metabolic process (GO:0046519) | 3.81537166 |
| 40 | neutrophil activation (GO:0042119) | 3.73085436 |
| 41 | sphingosine metabolic process (GO:0006670) | 3.71517078 |
| 42 | regulation of memory T cell differentiation (GO:0043380) | 3.70169679 |
| 43 | peptide cross-linking (GO:0018149) | 3.67183373 |
| 44 | interferon-gamma production (GO:0032609) | 3.65683479 |
| 45 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.64078540 |
| 46 | epidermal cell differentiation (GO:0009913) | 3.63861429 |
| 47 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.63052852 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.61547526 |
| 49 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.58878460 |
| 50 | negative regulation of adaptive immune response (GO:0002820) | 3.58506282 |
| 51 | regulation of cholesterol homeostasis (GO:2000188) | 3.58212417 |
| 52 | intestinal epithelial cell development (GO:0060576) | 3.57799895 |
| 53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.57081671 |
| 54 | primary alcohol catabolic process (GO:0034310) | 3.54839918 |
| 55 | leukocyte aggregation (GO:0070486) | 3.54646367 |
| 56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49413369 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49413369 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.46562636 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.46562636 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.44334159 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43610368 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 3.43610368 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43610368 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43610368 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43610368 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.43610368 |
| 67 | diol metabolic process (GO:0034311) | 3.42610216 |
| 68 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.41527831 |
| 69 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.41365978 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 3.40989727 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.37603661 |
| 72 | * molting cycle (GO:0042303) | 3.37004067 |
| 73 | * hair cycle (GO:0042633) | 3.37004067 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.32514305 |
| 75 | L-phenylalanine metabolic process (GO:0006558) | 3.32514305 |
| 76 | kynurenine metabolic process (GO:0070189) | 3.31485702 |
| 77 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.31405683 |
| 78 | DNA deamination (GO:0045006) | 3.30880184 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28845172 |
| 80 | ethanol metabolic process (GO:0006067) | 3.27248440 |
| 81 | granulocyte activation (GO:0036230) | 3.26820327 |
| 82 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.26514484 |
| 83 | T-helper cell differentiation (GO:0042093) | 3.26514484 |
| 84 | urea cycle (GO:0000050) | 3.26061437 |
| 85 | urea metabolic process (GO:0019627) | 3.26061437 |
| 86 | regulation of cell killing (GO:0031341) | 3.24925667 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.24889025 |
| 88 | mast cell activation (GO:0045576) | 3.24530399 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 3.21335747 |
| 90 | activated T cell proliferation (GO:0050798) | 3.19373095 |
| 91 | positive regulation of humoral immune response (GO:0002922) | 3.19079603 |
| 92 | positive regulation of cell killing (GO:0031343) | 3.16830036 |
| 93 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.16441035 |
| 94 | epidermis development (GO:0008544) | 3.16347661 |
| 95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14990939 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 3.14897658 |
| 97 | cellular extravasation (GO:0045123) | 3.13431495 |
| 98 | positive T cell selection (GO:0043368) | 3.12893577 |
| 99 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.12823208 |
| 100 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12265365 |
| 101 | cytidine metabolic process (GO:0046087) | 3.11920694 |
| 102 | cytidine catabolic process (GO:0006216) | 3.11920694 |
| 103 | cytidine deamination (GO:0009972) | 3.11920694 |
| 104 | regulation of interleukin-8 secretion (GO:2000482) | 3.09258921 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 3.08960219 |
| 106 | alpha-beta T cell differentiation (GO:0046632) | 3.08430122 |
| 107 | indole-containing compound catabolic process (GO:0042436) | 3.06840295 |
| 108 | indolalkylamine catabolic process (GO:0046218) | 3.06840295 |
| 109 | tryptophan catabolic process (GO:0006569) | 3.06840295 |
| 110 | fibrinolysis (GO:0042730) | 3.06626395 |
| 111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05663035 |
| 112 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05663035 |
| 113 | ectoderm development (GO:0007398) | 3.04086192 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 3.03723854 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 3.02540410 |
| 116 | high-density lipoprotein particle remodeling (GO:0034375) | 3.01545688 |
| 117 | intermediate filament organization (GO:0045109) | 2.98862503 |
| 118 | alpha-beta T cell activation (GO:0046631) | 2.97925942 |
| 119 | T cell selection (GO:0045058) | 2.97194566 |
| 120 | negative regulation of sterol transport (GO:0032372) | 2.97118641 |
| 121 | negative regulation of cholesterol transport (GO:0032375) | 2.97118641 |
| 122 | cysteine metabolic process (GO:0006534) | 2.96352754 |
| 123 | detection of external biotic stimulus (GO:0098581) | 2.94690073 |
| 124 | neutrophil mediated immunity (GO:0002446) | 2.93923740 |
| 125 | regulation of protein activation cascade (GO:2000257) | 2.93664053 |
| 126 | regulation of T cell mediated immunity (GO:0002709) | 2.92612750 |
| 127 | fatty acid elongation (GO:0030497) | 2.92602200 |
| 128 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.91482072 |
| 129 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.91482072 |
| 130 | T cell differentiation involved in immune response (GO:0002292) | 2.91482072 |
| 131 | leukocyte degranulation (GO:0043299) | 2.90183309 |
| 132 | cellular defense response (GO:0006968) | 2.89111368 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88211083 |
| 134 | bile acid biosynthetic process (GO:0006699) | 2.87714329 |
| 135 | negative regulation of B cell activation (GO:0050869) | 2.87380628 |
| 136 | nitrogen cycle metabolic process (GO:0071941) | 2.87277355 |
| 137 | linoleic acid metabolic process (GO:0043651) | 2.87105120 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.86578313 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.86374849 |
| 140 | hormone catabolic process (GO:0042447) | 2.86159323 |
| 141 | positive regulation of tolerance induction (GO:0002645) | 2.84768420 |
| 142 | positive regulation of mRNA catabolic process (GO:0061014) | 2.82130886 |
| 143 | regulation of phospholipase A2 activity (GO:0032429) | 2.82020198 |
| 144 | negative regulation of lipase activity (GO:0060192) | 2.81673791 |
| 145 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.81142340 |
| 146 | complement activation, alternative pathway (GO:0006957) | 2.80978897 |
| 147 | detection of molecule of bacterial origin (GO:0032490) | 2.80836861 |
| 148 | positive regulation of T cell mediated immunity (GO:0002711) | 2.80629952 |
| 149 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.80551311 |
| 150 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79978835 |
| 151 | protein carboxylation (GO:0018214) | 2.79978835 |
| 152 | microglial cell activation (GO:0001774) | 2.79910028 |
| 153 | tryptophan metabolic process (GO:0006568) | 2.79879107 |
| 154 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.79830721 |
| 155 | negative regulation of fibrinolysis (GO:0051918) | 2.79596206 |
| 156 | regulation of complement activation (GO:0030449) | 2.77725475 |
| 157 | positive regulation of granulocyte differentiation (GO:0030854) | 2.77557046 |
| 158 | retinal metabolic process (GO:0042574) | 2.76893935 |
| 159 | amino-acid betaine metabolic process (GO:0006577) | 2.76836521 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.76602054 |
| 161 | regulation of germinal center formation (GO:0002634) | 2.76259896 |
| 162 | bile acid and bile salt transport (GO:0015721) | 2.76251271 |
| 163 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75974344 |
| 164 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.75306244 |
| 165 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.75306244 |
| 166 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73866156 |
| 167 | acylglycerol homeostasis (GO:0055090) | 2.73798218 |
| 168 | triglyceride homeostasis (GO:0070328) | 2.73798218 |
| 169 | regulation of fibrinolysis (GO:0051917) | 2.70968578 |
| 170 | hepatocyte apoptotic process (GO:0097284) | 2.70131564 |
| 171 | regulation of ruffle assembly (GO:1900027) | 2.70112947 |
| 172 | homocysteine metabolic process (GO:0050667) | 2.70020702 |
| 173 | reverse cholesterol transport (GO:0043691) | 2.64740722 |
| 174 | imidazole-containing compound metabolic process (GO:0052803) | 2.60706131 |
| 175 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.60610908 |
| 176 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.60610908 |
| 177 | bile acid metabolic process (GO:0008206) | 2.59897877 |
| 178 | intestinal absorption (GO:0050892) | 2.54701112 |
| 179 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53481707 |
| 180 | atrioventricular valve morphogenesis (GO:0003181) | 2.50577364 |
| 181 | acute-phase response (GO:0006953) | 2.49975189 |
| 182 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.49491230 |
| 183 | response to phenylpropanoid (GO:0080184) | 2.49080404 |
| 184 | defense response to fungus (GO:0050832) | 2.48327664 |
| 185 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.45974204 |
| 186 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.43714794 |
| 187 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.42294094 |
| 188 | positive regulation of lipid catabolic process (GO:0050996) | 2.41974655 |
| 189 | protein-lipid complex remodeling (GO:0034368) | 2.40207948 |
| 190 | macromolecular complex remodeling (GO:0034367) | 2.40207948 |
| 191 | plasma lipoprotein particle remodeling (GO:0034369) | 2.40207948 |
| 192 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.39639364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.98664168 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.78810618 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52265382 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.50781702 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23184868 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.98592067 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.80833424 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76635384 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71014947 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.57134529 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54839999 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.50899219 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49991416 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.37824634 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34327261 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33675747 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31529033 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26797413 |
| 19 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.21054741 |
| 20 | GATA3_26560356_Chip-Seq_TH2_Human | 2.20219277 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17997798 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.14570376 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06723815 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05997091 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.05712247 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05588389 |
| 27 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.00231583 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.8348082 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99211482 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98032459 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.93613911 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.93613911 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90599816 |
| 34 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.88550270 |
| 35 | * MYB_26560356_Chip-Seq_TH1_Human | 1.88352743 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.84759220 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84070266 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.81444582 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80443527 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.76838695 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76500098 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72354575 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70323525 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69765602 |
| 45 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66054164 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63517024 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61439892 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59201561 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58377408 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54215977 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52019958 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50556498 |
| 53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49193449 |
| 54 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.49116603 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48875258 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47991197 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47697244 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45519452 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.45459767 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.42278967 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41501735 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39235402 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39012990 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37447947 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36602267 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34903095 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33831556 |
| 68 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33777529 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33204018 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33086024 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29584595 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29357433 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25161517 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24940777 |
| 75 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.23915351 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21924382 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21258940 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19723529 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18275170 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17118025 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17024786 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13517109 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12960409 |
| 84 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.12741647 |
| 85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11729509 |
| 86 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.11077483 |
| 87 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07651703 |
| 88 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07024841 |
| 89 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06723630 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06334148 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05557336 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01861806 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01699537 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01140349 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00585013 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00075041 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99631151 |
| 98 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99593078 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99051736 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98826837 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98732158 |
| 102 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98659061 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96046524 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95379216 |
| 105 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94700756 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94695084 |
| 107 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94592003 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93609035 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92712204 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92701555 |
| 111 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92341579 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92083832 |
| 113 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92078338 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91611713 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91305511 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90794379 |
| 117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90766682 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90014015 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89877191 |
| 120 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89765924 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89440689 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89136646 |
| 123 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87692051 |
| 124 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.87686674 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87552165 |
| 126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.87430972 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87229231 |
| 128 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87004003 |
| 129 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86645034 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86563145 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86447219 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85844526 |
| 133 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85706961 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85084616 |
| 135 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83610241 |
| 136 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83122277 |
| 137 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82518596 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81980458 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 0.81374887 |
| 140 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80813324 |
| 141 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80665684 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80027883 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78305935 |
| 144 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.78182880 |
| 145 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77958931 |
| 146 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76724098 |
| 147 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76615391 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76575716 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76118770 |
| 150 | MAF_26560356_Chip-Seq_TH1_Human | 0.73858755 |
| 151 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.72642127 |
| 152 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.71113549 |
| 153 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70552707 |
| 154 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70033510 |
| 155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69373350 |
| 156 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.68828273 |
| 157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68420262 |
| 158 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67430092 |
| 159 | UTX_26944678_Chip-Seq_JUKART_Human | 0.65898803 |
| 160 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.64109164 |
| 161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63965183 |
| 162 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.62641861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 5.85493019 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.70639713 |
| 3 | MP0005501_abnormal_skin_physiology | 3.63238091 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.48206274 |
| 5 | MP0005275_abnormal_skin_tensile | 3.43735130 |
| 6 | MP0005451_abnormal_body_composition | 3.34277285 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.09878705 |
| 8 | MP0005360_urolithiasis | 3.09150214 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.88215660 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.86663961 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.81740455 |
| 12 | MP0002254_reproductive_system_inflammat | 2.76579309 |
| 13 | * MP0001216_abnormal_epidermal_layer | 2.69860246 |
| 14 | * MP0004947_skin_inflammation | 2.65029983 |
| 15 | MP0003941_abnormal_skin_development | 2.64217252 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.51507269 |
| 17 | * MP0002060_abnormal_skin_morphology | 2.48781403 |
| 18 | MP0005365_abnormal_bile_salt | 2.47321770 |
| 19 | MP0000579_abnormal_nail_morphology | 2.35874444 |
| 20 | MP0002419_abnormal_innate_immunity | 2.29425988 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.28221225 |
| 22 | MP0001819_abnormal_immune_cell | 2.25903260 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.25186838 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 2.21922239 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11798696 |
| 26 | MP0002098_abnormal_vibrissa_morphology | 2.10370331 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.08936336 |
| 28 | * MP0010771_integument_phenotype | 2.05583263 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 2.01523016 |
| 30 | * MP0004381_abnormal_hair_follicle | 1.98594236 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.97718317 |
| 32 | MP0000383_abnormal_hair_follicle | 1.94170322 |
| 33 | MP0000647_abnormal_sebaceous_gland | 1.88422103 |
| 34 | MP0006082_CNS_inflammation | 1.85886389 |
| 35 | * MP0000377_abnormal_hair_follicle | 1.79545762 |
| 36 | * MP0002398_abnormal_bone_marrow | 1.78452834 |
| 37 | MP0004264_abnormal_extraembryonic_tissu | 1.76893977 |
| 38 | MP0000716_abnormal_immune_system | 1.71266701 |
| 39 | MP0003252_abnormal_bile_duct | 1.70638562 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.66559605 |
| 41 | MP0003303_peritoneal_inflammation | 1.65482516 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.63972427 |
| 43 | MP0002132_abnormal_respiratory_system | 1.61073842 |
| 44 | MP0003436_decreased_susceptibility_to | 1.59552951 |
| 45 | * MP0000689_abnormal_spleen_morphology | 1.58950454 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.55718002 |
| 47 | MP0005310_abnormal_salivary_gland | 1.54934715 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.53440337 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.52719106 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.50419738 |
| 51 | MP0002722_abnormal_immune_system | 1.46697456 |
| 52 | MP0002163_abnormal_gland_morphology | 1.45278535 |
| 53 | MP0010329_abnormal_lipoprotein_level | 1.43930570 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.43677403 |
| 55 | MP0000467_abnormal_esophagus_morphology | 1.43013716 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.40609476 |
| 57 | MP0001191_abnormal_skin_condition | 1.39580699 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.35524471 |
| 59 | * MP0009931_abnormal_skin_appearance | 1.34616929 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.34564700 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.33577623 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.32925680 |
| 63 | * MP0000427_abnormal_hair_cycle | 1.30539730 |
| 64 | MP0002429_abnormal_blood_cell | 1.27984613 |
| 65 | MP0005023_abnormal_wound_healing | 1.27971949 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 1.27324849 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.25200992 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.24662638 |
| 69 | MP0002009_preneoplasia | 1.23976780 |
| 70 | MP0001873_stomach_inflammation | 1.19712931 |
| 71 | MP0003195_calcinosis | 1.18475830 |
| 72 | MP0005083_abnormal_biliary_tract | 1.18350176 |
| 73 | MP0000685_abnormal_immune_system | 1.17264494 |
| 74 | MP0001851_eye_inflammation | 1.16608704 |
| 75 | * MP0000609_abnormal_liver_physiology | 1.14777175 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.12615562 |
| 77 | MP0009840_abnormal_foam_cell | 1.11485240 |
| 78 | MP0003828_pulmonary_edema | 1.11373069 |
| 79 | MP0009764_decreased_sensitivity_to | 1.11153491 |
| 80 | MP0001919_abnormal_reproductive_system | 1.09884154 |
| 81 | * MP0000367_abnormal_coat/_hair | 1.07315639 |
| 82 | * MP0001243_abnormal_dermal_layer | 1.03650634 |
| 83 | MP0008877_abnormal_DNA_methylation | 1.03437320 |
| 84 | MP0003866_abnormal_defecation | 1.03060728 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 1.02391667 |
| 86 | MP0003045_fibrosis | 1.01876068 |
| 87 | MP0008872_abnormal_physiological_respon | 0.99740843 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.99240862 |
| 89 | MP0003787_abnormal_imprinting | 0.96235053 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.94809619 |
| 91 | MP0001881_abnormal_mammary_gland | 0.94334327 |
| 92 | MP0000627_abnormal_mammary_gland | 0.93399514 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.92059023 |
| 94 | MP0009785_altered_susceptibility_to | 0.91284453 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.88510043 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.88204310 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.87833195 |
| 98 | MP0004883_abnormal_blood_vessel | 0.87691934 |
| 99 | MP0002006_tumorigenesis | 0.87138965 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.86650071 |
| 101 | MP0001853_heart_inflammation | 0.85755390 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.85188835 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.85086582 |
| 104 | MP0004484_altered_response_of | 0.84629744 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.83692053 |
| 106 | MP0000604_amyloidosis | 0.83314924 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.82593882 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.82341296 |
| 109 | MP0000566_synostosis | 0.81574820 |
| 110 | MP0000762_abnormal_tongue_morphology | 0.81490671 |
| 111 | MP0005332_abnormal_amino_acid | 0.78478294 |
| 112 | MP0001800_abnormal_humoral_immune | 0.77770334 |
| 113 | MP0009763_increased_sensitivity_to | 0.76814229 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.76775014 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.76406704 |
| 116 | MP0000858_altered_metastatic_potential | 0.75515151 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.75332797 |
| 118 | MP0008260_abnormal_autophagy | 0.74404062 |
| 119 | MP0003878_abnormal_ear_physiology | 0.73674594 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.73674594 |
| 121 | MP0009053_abnormal_anal_canal | 0.73479443 |
| 122 | * MP0001845_abnormal_inflammatory_respons | 0.72841843 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.72548212 |
| 124 | MP0001790_abnormal_immune_system | 0.71600272 |
| 125 | MP0005387_immune_system_phenotype | 0.71600272 |
| 126 | * MP0001765_abnormal_ion_homeostasis | 0.71416635 |
| 127 | MP0005025_abnormal_response_to | 0.71344344 |
| 128 | MP0008004_abnormal_stomach_pH | 0.70052821 |
| 129 | MP0003329_amyloid_beta_deposits | 0.69158149 |
| 130 | MP0002933_joint_inflammation | 0.68664759 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.68048946 |
| 132 | MP0005164_abnormal_response_to | 0.67722150 |
| 133 | MP0008995_early_reproductive_senescence | 0.67254754 |
| 134 | MP0008057_abnormal_DNA_replication | 0.65729988 |
| 135 | MP0006054_spinal_hemorrhage | 0.65661565 |
| 136 | MP0001346_abnormal_lacrimal_gland | 0.65570058 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.64810709 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.64538478 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.64236337 |
| 140 | MP0003724_increased_susceptibility_to | 0.63581656 |
| 141 | MP0005389_reproductive_system_phenotype | 0.62430082 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.62194338 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.61758926 |
| 144 | MP0003868_abnormal_feces_composition | 0.60696480 |
| 145 | MP0005390_skeleton_phenotype | 0.60686559 |
| 146 | MP0003011_delayed_dark_adaptation | 0.60383268 |
| 147 | MP0008469_abnormal_protein_level | 0.60012471 |
| 148 | MP0008961_abnormal_basal_metabolism | 0.59365632 |
| 149 | MP0005671_abnormal_response_to | 0.58080390 |
| 150 | MP0009333_abnormal_splenocyte_physiolog | 0.57093247 |
| 151 | MP0002148_abnormal_hypersensitivity_rea | 0.56063647 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.55573841 |
| 153 | MP0002723_abnormal_immune_serum | 0.55072025 |
| 154 | MP0002405_respiratory_system_inflammati | 0.54274699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.24606206 |
| 2 | Increased IgE level (HP:0003212) | 5.70479408 |
| 3 | Onycholysis (HP:0001806) | 5.46813950 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.01020593 |
| 5 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.96876253 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.94197773 |
| 7 | Optic neuritis (HP:0100653) | 4.94197773 |
| 8 | Plantar hyperkeratosis (HP:0007556) | 4.93780672 |
| 9 | Hypotrichosis (HP:0001006) | 4.87437823 |
| 10 | Myositis (HP:0100614) | 4.84199180 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.72029361 |
| 12 | Orchitis (HP:0100796) | 4.67937352 |
| 13 | T lymphocytopenia (HP:0005403) | 4.60163721 |
| 14 | Woolly hair (HP:0002224) | 4.58969013 |
| 15 | Abnormality of nail color (HP:0100643) | 4.38557424 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 4.24438566 |
| 17 | Fragile nails (HP:0001808) | 4.07188658 |
| 18 | Milia (HP:0001056) | 3.99022240 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.95735942 |
| 20 | Palmar hyperkeratosis (HP:0010765) | 3.90883825 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.81744348 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78867194 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.69216216 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.64277122 |
| 25 | Abnormality of T cells (HP:0002843) | 3.61205226 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.57273388 |
| 27 | Erythroderma (HP:0001019) | 3.55713760 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.53643622 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.53097158 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.52048311 |
| 31 | Pili torti (HP:0003777) | 3.48827225 |
| 32 | Xanthomatosis (HP:0000991) | 3.48027413 |
| 33 | Parakeratosis (HP:0001036) | 3.46472648 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.45151396 |
| 35 | Recurrent abscess formation (HP:0002722) | 3.43467848 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.34364808 |
| 37 | Nail dystrophy (HP:0008404) | 3.32465236 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.29321690 |
| 39 | IgG deficiency (HP:0004315) | 3.26287327 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 3.26185965 |
| 41 | Abnormality of eosinophils (HP:0001879) | 3.21768556 |
| 42 | Erythema (HP:0010783) | 3.21144211 |
| 43 | Gangrene (HP:0100758) | 3.17184513 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.17155603 |
| 45 | Vasculitis (HP:0002633) | 3.15061554 |
| 46 | Abnormal blistering of the skin (HP:0008066) | 3.11442289 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.10948315 |
| 48 | Increased IgM level (HP:0003496) | 3.10231203 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 3.09930285 |
| 50 | Encephalitis (HP:0002383) | 3.07898373 |
| 51 | Alopecia of scalp (HP:0002293) | 3.06061621 |
| 52 | Pustule (HP:0200039) | 3.05771330 |
| 53 | Thyroiditis (HP:0100646) | 3.04544220 |
| 54 | Recurrent skin infections (HP:0001581) | 3.03849321 |
| 55 | Thick nail (HP:0001805) | 3.02388423 |
| 56 | Curly hair (HP:0002212) | 3.00870385 |
| 57 | Leukocytosis (HP:0001974) | 3.00266974 |
| 58 | Lip pit (HP:0100267) | 2.93558435 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92493839 |
| 60 | Eosinophilia (HP:0001880) | 2.91621373 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.82105667 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.81496399 |
| 63 | Ectropion (HP:0000656) | 2.80397847 |
| 64 | Pruritus (HP:0000989) | 2.78338082 |
| 65 | Vascular calcification (HP:0004934) | 2.76997775 |
| 66 | Hypochromic anemia (HP:0001931) | 2.76456197 |
| 67 | Anorexia (HP:0002039) | 2.74245412 |
| 68 | Arterial thrombosis (HP:0004420) | 2.70736828 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70522865 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68931969 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68931969 |
| 72 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66994259 |
| 73 | Hemoptysis (HP:0002105) | 2.66423392 |
| 74 | Meningitis (HP:0001287) | 2.65582265 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.64152122 |
| 76 | Atrophic scars (HP:0001075) | 2.64090433 |
| 77 | Corneal erosion (HP:0200020) | 2.61945996 |
| 78 | Epidermoid cyst (HP:0200040) | 2.59191133 |
| 79 | Prolonged partial thromboplastin time (HP:0003645) | 2.58149842 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.55676662 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 2.55542581 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.55452028 |
| 83 | Granulocytopenia (HP:0001913) | 2.55343326 |
| 84 | Hypohidrosis (HP:0000966) | 2.53842416 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.52727267 |
| 86 | Abnormality of the gastric mucosa (HP:0004295) | 2.51741059 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 2.50143224 |
| 88 | Chronic diarrhea (HP:0002028) | 2.47255529 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.46121257 |
| 90 | Hypolipoproteinemia (HP:0010981) | 2.45097611 |
| 91 | Fat malabsorption (HP:0002630) | 2.44422315 |
| 92 | Joint swelling (HP:0001386) | 2.41961652 |
| 93 | Acanthosis nigricans (HP:0000956) | 2.41887413 |
| 94 | Alveolar cell carcinoma (HP:0006519) | 2.41168613 |
| 95 | Ventricular tachycardia (HP:0004756) | 2.40129030 |
| 96 | Stomach cancer (HP:0012126) | 2.38888973 |
| 97 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.37666356 |
| 98 | Myocardial infarction (HP:0001658) | 2.34109750 |
| 99 | Episodic fever (HP:0001954) | 2.33162937 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.32472867 |
| 101 | Complement deficiency (HP:0004431) | 2.30228876 |
| 102 | Dehydration (HP:0001944) | 2.30178748 |
| 103 | Recurrent viral infections (HP:0004429) | 2.29887774 |
| 104 | Hyperlipoproteinemia (HP:0010980) | 2.26772806 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.25047172 |
| 106 | Palmoplantar keratoderma (HP:0000982) | 2.24108898 |
| 107 | Sparse eyelashes (HP:0000653) | 2.22851373 |
| 108 | Pulmonary embolism (HP:0002204) | 2.22737403 |
| 109 | Malnutrition (HP:0004395) | 2.20471183 |
| 110 | Chest pain (HP:0100749) | 2.18137571 |
| 111 | Petechiae (HP:0000967) | 2.17584115 |
| 112 | Oral leukoplakia (HP:0002745) | 2.17146314 |
| 113 | Conjunctival hamartoma (HP:0100780) | 2.16469539 |
| 114 | Keratitis (HP:0000491) | 2.15011105 |
| 115 | Acute hepatic failure (HP:0006554) | 2.13067308 |
| 116 | Obstructive lung disease (HP:0006536) | 2.11547708 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11547708 |
| 118 | Combined immunodeficiency (HP:0005387) | 2.11467814 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 2.10813977 |
| 120 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10365871 |
| 121 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08525068 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 2.07910816 |
| 123 | Spontaneous hematomas (HP:0007420) | 2.07684246 |
| 124 | Esophageal varix (HP:0002040) | 2.02219969 |
| 125 | Hyperammonemia (HP:0001987) | 2.00777105 |
| 126 | Abnormality of the pleura (HP:0002103) | 2.00154360 |
| 127 | Bronchitis (HP:0012387) | 1.98209459 |
| 128 | Urticaria (HP:0001025) | 1.97184049 |
| 129 | Abnormality of complement system (HP:0005339) | 1.96895344 |
| 130 | Brittle hair (HP:0002299) | 1.96549782 |
| 131 | Ridged nail (HP:0001807) | 1.96484555 |
| 132 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92594801 |
| 133 | Abnormality of the prostate (HP:0008775) | 1.91661458 |
| 134 | Advanced eruption of teeth (HP:0006288) | 1.91177342 |
| 135 | Interstitial pulmonary disease (HP:0006530) | 1.90252823 |
| 136 | Panhypogammaglobulinemia (HP:0003139) | 1.90018560 |
| 137 | Anhidrosis (HP:0000970) | 1.89537660 |
| 138 | Skin ulcer (HP:0200042) | 1.87805184 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.86929152 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.86929152 |
| 141 | Gingivitis (HP:0000230) | 1.85539819 |
| 142 | Chronic otitis media (HP:0000389) | 1.85293104 |
| 143 | Lack of skin elasticity (HP:0100679) | 1.84826391 |
| 144 | Stomatitis (HP:0010280) | 1.84391916 |
| 145 | Villous atrophy (HP:0011473) | 1.84051176 |
| 146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.84051176 |
| 147 | Dry skin (HP:0000958) | 1.83989101 |
| 148 | Ileus (HP:0002595) | 1.83471767 |
| 149 | Oligodontia (HP:0000677) | 1.81811163 |
| 150 | Epistaxis (HP:0000421) | 1.80877970 |
| 151 | Recurrent sinusitis (HP:0011108) | 1.80695031 |
| 152 | Abnormality of the Achilles tendon (HP:0005109) | 1.80431982 |
| 153 | Bronchiectasis (HP:0002110) | 1.80318253 |
| 154 | Premature loss of primary teeth (HP:0006323) | 1.79473212 |
| 155 | Abnormality of the renal cortex (HP:0011035) | 1.79096662 |
| 156 | Sepsis (HP:0100806) | 1.77251838 |
| 157 | Rickets (HP:0002748) | 1.76579932 |
| 158 | Joint hemorrhage (HP:0005261) | 1.75870466 |
| 159 | Gingival bleeding (HP:0000225) | 1.75288927 |
| 160 | Chronic sinusitis (HP:0011109) | 1.75281472 |
| 161 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.74370508 |
| 162 | Steatorrhea (HP:0002570) | 1.73271456 |
| 163 | Prostate neoplasm (HP:0100787) | 1.73082724 |
| 164 | Hypoproteinemia (HP:0003075) | 1.73003275 |
| 165 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.72394560 |
| 166 | Vertigo (HP:0002321) | 1.71753416 |
| 167 | Type I diabetes mellitus (HP:0100651) | 1.70522108 |
| 168 | Abnormal hemoglobin (HP:0011902) | 1.70265012 |
| 169 | Blepharitis (HP:0000498) | 1.67224304 |
| 170 | Increased mean platelet volume (HP:0011877) | 1.66175047 |
| 171 | Thin bony cortex (HP:0002753) | 1.65979866 |
| 172 | Hypoplasia of dental enamel (HP:0006297) | 1.65246125 |
| 173 | Abnormality of secondary sexual hair (HP:0009888) | 1.65222701 |
| 174 | Abnormality of the axillary hair (HP:0100134) | 1.65222701 |
| 175 | Late onset (HP:0003584) | 1.64952517 |
| 176 | Ventricular fibrillation (HP:0001663) | 1.62905864 |
| 177 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61911886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.50561456 |
| 2 | MST4 | 4.23901682 |
| 3 | MST1R | 3.14548622 |
| 4 | MAP3K3 | 2.81353994 |
| 5 | ERN1 | 2.75652937 |
| 6 | FER | 2.71651368 |
| 7 | RIPK4 | 2.61084617 |
| 8 | FGFR4 | 2.54251341 |
| 9 | SIK3 | 2.40990197 |
| 10 | IRAK4 | 2.31991569 |
| 11 | TRIB3 | 2.22409299 |
| 12 | STK10 | 2.22216254 |
| 13 | MAPKAPK3 | 2.22072236 |
| 14 | PTK6 | 2.21217922 |
| 15 | FRK | 2.21071451 |
| 16 | FES | 2.18402791 |
| 17 | LATS1 | 2.13525899 |
| 18 | SIK1 | 1.93786779 |
| 19 | MAP3K14 | 1.87442764 |
| 20 | EPHB1 | 1.72541924 |
| 21 | PIK3CG | 1.63954357 |
| 22 | TYK2 | 1.61939152 |
| 23 | RPS6KB2 | 1.61573358 |
| 24 | EPHA3 | 1.61290175 |
| 25 | LRRK2 | 1.59767230 |
| 26 | MAP3K2 | 1.52986623 |
| 27 | ITK | 1.52246708 |
| 28 | BMPR2 | 1.51580484 |
| 29 | EIF2AK3 | 1.51121136 |
| 30 | IRAK1 | 1.46559655 |
| 31 | TESK1 | 1.40078635 |
| 32 | STK24 | 1.37949193 |
| 33 | SYK | 1.37735662 |
| 34 | MAP3K12 | 1.33091039 |
| 35 | PTK2 | 1.31509720 |
| 36 | MAP4K1 | 1.30832352 |
| 37 | ZAP70 | 1.28295301 |
| 38 | STK38L | 1.27072074 |
| 39 | TRPM7 | 1.26078565 |
| 40 | TBK1 | 1.20030652 |
| 41 | OXSR1 | 1.16523267 |
| 42 | BLK | 1.16386818 |
| 43 | CAMKK2 | 1.15266296 |
| 44 | MAP2K2 | 1.15146543 |
| 45 | NEK9 | 1.13640673 |
| 46 | AKT3 | 1.12874579 |
| 47 | IKBKE | 1.11945845 |
| 48 | MAP3K7 | 1.11401423 |
| 49 | EPHB2 | 1.10550336 |
| 50 | RPS6KA4 | 1.08919351 |
| 51 | RIPK1 | 1.08831511 |
| 52 | FGFR3 | 1.07908671 |
| 53 | CSK | 1.05609374 |
| 54 | FGFR1 | 1.04862661 |
| 55 | TXK | 1.03477619 |
| 56 | MAP2K3 | 1.01265095 |
| 57 | LYN | 1.00735893 |
| 58 | JAK1 | 0.99433413 |
| 59 | ERBB4 | 0.97578270 |
| 60 | MAP3K13 | 0.97431586 |
| 61 | TAOK1 | 0.92483502 |
| 62 | MAP3K9 | 0.91434989 |
| 63 | MAP4K2 | 0.89223771 |
| 64 | JAK3 | 0.89078858 |
| 65 | IRAK3 | 0.89068889 |
| 66 | MARK3 | 0.87547121 |
| 67 | CDK6 | 0.86572410 |
| 68 | EEF2K | 0.84813218 |
| 69 | MAP3K11 | 0.83861843 |
| 70 | MET | 0.83684474 |
| 71 | DAPK2 | 0.82627357 |
| 72 | MAP3K1 | 0.82424461 |
| 73 | PIM2 | 0.82111075 |
| 74 | BCKDK | 0.81444083 |
| 75 | GRK6 | 0.79815396 |
| 76 | SGK2 | 0.78497613 |
| 77 | STK39 | 0.78103632 |
| 78 | TESK2 | 0.77884506 |
| 79 | MAP3K10 | 0.76024214 |
| 80 | IKBKB | 0.75127037 |
| 81 | CHUK | 0.74066086 |
| 82 | TTN | 0.73652922 |
| 83 | PKN2 | 0.73192510 |
| 84 | GRK7 | 0.73075203 |
| 85 | ACVR1B | 0.71721757 |
| 86 | KIT | 0.71604922 |
| 87 | TAOK3 | 0.71255505 |
| 88 | DYRK1B | 0.69580272 |
| 89 | TLK1 | 0.69513802 |
| 90 | MAP2K6 | 0.68196027 |
| 91 | JAK2 | 0.66436850 |
| 92 | CSF1R | 0.63221521 |
| 93 | MAP3K8 | 0.62001541 |
| 94 | PDK1 | 0.61335273 |
| 95 | ADRBK2 | 0.61230420 |
| 96 | SGK3 | 0.60229474 |
| 97 | NLK | 0.59799285 |
| 98 | TRIM28 | 0.59390020 |
| 99 | BCR | 0.57848724 |
| 100 | YES1 | 0.56614768 |
| 101 | MAP2K1 | 0.56538201 |
| 102 | HIPK2 | 0.56245025 |
| 103 | GRK1 | 0.55268721 |
| 104 | STK3 | 0.55179775 |
| 105 | ADRBK1 | 0.54533647 |
| 106 | LIMK1 | 0.54347263 |
| 107 | MAP3K5 | 0.53446353 |
| 108 | NEK6 | 0.52336741 |
| 109 | HCK | 0.51991476 |
| 110 | MAPKAPK2 | 0.51615598 |
| 111 | PTK2B | 0.51352762 |
| 112 | TGFBR2 | 0.49533656 |
| 113 | PRKAA2 | 0.48839760 |
| 114 | IRAK2 | 0.48839248 |
| 115 | PIM1 | 0.47662000 |
| 116 | FGR | 0.47037164 |
| 117 | GRK5 | 0.46815531 |
| 118 | KDR | 0.46766109 |
| 119 | TNK2 | 0.45767391 |
| 120 | PASK | 0.45558847 |
| 121 | MATK | 0.44353331 |
| 122 | TEC | 0.44303531 |
| 123 | PAK3 | 0.43798788 |
| 124 | MAPK11 | 0.43749505 |
| 125 | INSRR | 0.43470804 |
| 126 | IGF1R | 0.42598238 |
| 127 | NUAK1 | 0.42367980 |
| 128 | BTK | 0.41352522 |
| 129 | PRKCQ | 0.39266249 |
| 130 | ERBB2 | 0.39234145 |
| 131 | SGK223 | 0.37997409 |
| 132 | SGK494 | 0.37997409 |
| 133 | LMTK2 | 0.37416794 |
| 134 | LCK | 0.37198918 |
| 135 | EGFR | 0.37067201 |
| 136 | PRKG2 | 0.35877466 |
| 137 | PRKCI | 0.35284539 |
| 138 | GSK3A | 0.34583253 |
| 139 | ABL1 | 0.32788135 |
| 140 | PIK3CA | 0.32684088 |
| 141 | ERBB3 | 0.32166131 |
| 142 | FGFR2 | 0.30753067 |
| 143 | STK38 | 0.30494132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06437702 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.91618559 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56899950 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53654431 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.52812612 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.50644273 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.42574583 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.33138576 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28576840 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.23677758 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.22541080 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.21396947 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18433809 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.12985752 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12385630 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09849286 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05101233 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.01810364 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.01770421 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.96665687 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92153360 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89745078 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85888303 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81111862 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79649130 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72328309 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67122077 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58943489 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53105219 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52615833 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.52228484 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51207329 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50464404 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.50415499 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48818840 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46353641 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.45300368 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40716047 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40174039 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39623052 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.34499841 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.31827927 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27969854 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25920271 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.21815963 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21762485 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21043788 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.20422250 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19586100 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17523388 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16000428 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.14971223 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14485618 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14444151 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13577466 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12527480 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10545879 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09725074 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.09340125 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09094585 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08966614 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08888309 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08587041 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07956452 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06782664 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 1.05543933 |
| 67 | Asthma_Homo sapiens_hsa05310 | 1.01296641 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 1.00244219 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97994750 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.95720084 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95353077 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94703542 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89968583 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87666772 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86898212 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86741055 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86359353 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84676848 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83944791 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83129201 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81317414 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.79254297 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79091458 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.78775898 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77782977 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75739415 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.75561058 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73226686 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72770800 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.71472338 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71423834 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70365154 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.70164469 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70062239 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69894758 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69222089 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68962796 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.66962568 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65550824 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65147372 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64305925 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64107923 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63623937 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63323549 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.62696128 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62614751 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60061001 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58991429 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58541521 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58135442 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57292233 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55828040 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55645244 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54191327 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53854478 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53637176 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53332990 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52905828 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.52202881 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52180019 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51556545 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50477131 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49642995 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49310274 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.48613543 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47445905 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47327073 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46832433 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46794544 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46402604 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45718392 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44959624 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44829885 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44772020 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43816566 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43625524 |
| 137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43606181 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42844164 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42711048 |
| 140 | Protein export_Homo sapiens_hsa03060 | 0.42640018 |
| 141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40136176 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39720352 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38782032 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.38081244 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37577487 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37476775 |
| 147 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36338143 |
| 148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35356656 |
| 149 | Phototransduction_Homo sapiens_hsa04744 | 0.35095096 |
| 150 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35038996 |
| 151 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35020269 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34571454 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34474300 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.34255695 |
| 155 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34238788 |
| 156 | Pertussis_Homo sapiens_hsa05133 | 0.34145074 |
| 157 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33789407 |
| 158 | RNA degradation_Homo sapiens_hsa03018 | 0.33653038 |
| 159 | Lysine degradation_Homo sapiens_hsa00310 | 0.31859498 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31158009 |
| 161 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28023380 |
| 162 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27095514 |

